Narcotic Drugs Amendment Act 2016

Overview

The Narcotic Drugs Amendment Act 2016 was enacted to address the evolving landscape surrounding the use of cannabis for medicinal and research purposes, and to align Australian law with the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol. This Act was introduced by the Parliament of Australia to modernise the Narcotic Drugs Act 1967. One of its key objectives is to establish a regulatory framework that permits the cultivation and production of cannabis for medicinal purposes, while ensuring strict controls and compliance with international obligations. This legislative amendment aims to facilitate the research and manufacturing of medicinal cannabis products, and to provide appropriate licensing and oversight mechanisms. By introducing this Act, the Parliament intended to fill a significant gap in the existing legal structure, allowing for the controlled use of cannabis in the medical field, thereby balancing public health concerns with the potential therapeutic benefits of cannabis.

Scope and Application

The Narcotic Drugs Amendment Act 2016 amends the Narcotic Drugs Act 1967, establishing a framework for the regulation of cannabis cultivation, production, and manufacture in Australia. This Act applies to natural and legal persons involved in these activities, including entities seeking to obtain licenses and permits for cultivating cannabis plants, producing cannabis or cannabis resin, and manufacturing drugs containing cannabis. The Act binds the Crown in all its capacities but does not make it liable to prosecution for offences. It applies across the Commonwealth of Australia and extends to external territories. The Act's provisions on licensing and permits for cannabis cultivation and production supersede conflicting State and Territory laws, except for those specifically prescribed by regulations. The Secretary of the Department of Health is tasked with assessing the suitability of applicants and their business associates to hold a licence, considering factors such as criminal history, financial stability, and compliance with relevant laws. The Act sets forth stringent conditions for both medicinal cannabis and research cannabis licences, including requirements for physical security, suitability of premises, and adherence to specified permit conditions. Licence holders must also inform relevant personnel of obligations, ensure the employment of suitable staff, and allow inspections and monitoring by authorised inspectors. The Act outlines offences and penalties for unauthorised cultivation and production, breach of licence conditions, and failure to comply with directions from the Secretary. Monitoring and enforcement powers are granted to authorised inspectors under the Regulatory Powers Act, with special provisions for entering and inspecting licensed premises. The Act also allows for the review of decisions by the Minister or an internal reviewer and provides for further review by the Administrative Appeals Tribunal. Additionally, the Act facilitates the authorisation of State and Territory agencies to carry out certain cannabis-related activities and mandates a review of its operation two years after the commencement of the amendments. Subordinate instruments may further specify details such as transitional arrangements, approval conditions for State and Territory agencies, and the imposition of penalties and fees. The Act ensures compliance with Australia's obligations under the Single Convention on Narcotic Drugs, 1961, as amended.

Key Provisions

• The Narcotic Drugs Amendment Act 2016 (C2016A00012) introduces significant changes to the Narcotic Drugs Act 1967, primarily focusing on the regulation of medicinal cannabis and the manufacture of drugs. The Act modifies the object and scope of the original Act to better align with Australia's obligations under the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol. It introduces two types of licences for cannabis: medicinal cannabis licences and cannabis research licences. Each of these licences requires the holder to obtain permits that specify the types of activities, quantities, and conditions under which cannabis plants can be cultivated and cannabis or cannabis resin can be produced. These permits are subject to variation and revocation by the Secretary. The Act also details the conditions that must be met for the grant of these licences, such as ensuring the physical security of cannabis plants, cannabis, and cannabis resin, and maintaining a fit and proper status of both the applicant and their business associates.
• The Act imposes several obligations on the parties it governs. Licence applicants must provide comprehensive information and documents as specified by the Secretary, including details on the activities they intend to undertake, the suitability of the proposed premises, and the financial and managerial capacity of the applicant and their associates. Licence holders must adhere to conditions imposed by the Secretary, including those related to the employment of suitable staff, compliance with permits, and reporting obligations. Additionally, the Secretary has the authority to require the destruction of cannabis plants, cannabis, and cannabis resin in the possession or control of the licence holder if certain conditions are met. The Act also mandates that certain information and documents be provided to the Secretary upon request, and failure to comply with these requirements can result in penalties.
• The Narcotic Drugs Amendment Act 2016 includes various offences and penalties for breaches. For example, cultivating or producing cannabis plants or cannabis resin without the appropriate licence or permit is a fault-based offence, carrying a penalty of up to 10 years imprisonment, a fine of 600 penalty units, or both. Breaches of licence conditions can also result in strict liability offences with penalties of 60 penalty units, as well as civil penalties of 1,000 penalty units. Similar provisions and penalties apply to the unauthorised manufacture of drugs and breaches of manufacture licence conditions. Additionally, failure to comply with directions issued by the Secretary or to supply drugs as directed can result in offences with penalties ranging from 60 to 600 penalty units, depending on the nature of the breach. The Act also includes provisions for the monitoring and enforcement of compliance through authorised inspectors, with specific powers to enter licensed premises, inspect activities, and enforce compliance with the Act.
• Review and oversight mechanisms are embedded within the Act. Decisions by the Secretary regarding the granting, variation, or revocation of licences and permits are reviewable, both internally and by the Administrative Appeals Tribunal. The Secretary has the power to issue directions to licence holders regarding the security of premises, handling of substances, and other regulatory compliance matters. Furthermore, the Act mandates a review of its operation two years after the commencement of the amendments, with the findings to be tabled in Parliament. The Secretary is also empowered to require information and documents from applicants and licence holders, with failure to comply resulting in strict liability offences and civil penalties. The Act ensures that authorised disclosures of information are protected under the Privacy Act 1988 and that the Crown is not liable to prosecution for offences under the Act.
• In summary, the Narcotic Drugs Amendment Act 2016 establishes a stringent regulatory framework for the cultivation and production of cannabis for medicinal purposes and research, alongside the manufacture of drugs. It imposes clear obligations on applicants and licence holders to ensure compliance with licensing conditions, physical security measures, and reporting requirements. Breaches of these obligations are met with significant penalties, including criminal and civil sanctions, to deter non-compliance and ensure the effective regulation of narcotic drugs in Australia.

Legal classification tags

Area of Law

Drug Control Law

Criminal Law

Instrument

Act

Concepts

Definitions & Interpretation

Commencement Provisions

Licensing & Registration

Offence Provisions

Civil Penalty Provisions

Monitoring & Enforcement

Review & Sunset Clauses